GVS
870976
Hangzhou CNCR-IT
300250
Shanghai Newtouch Software
688590
4
Ucap Cloud Information Technology Co.,Ltd
688228
5
Yangtze Optical Electronic
688143
US Stock MarketDetailed Quotes
NBY NovaBay Pharmaceuticals
- 0.6500
- -0.0601-8.46%
Trading Jan 24 10:14 ET
3.18MMarket Cap-0.01P/E (TTM)
0.7000High0.6368Low88.66KVolume0.6884Open0.7101Pre Close59.23KTurnover1.97%Turnover Ratio0.00P/E (Static)4.89MShares9.079052wk High2.98P/B2.93MFloat Cap0.361152wk Low--Dividend TTM4.50MShs Float130156.1979Historical High--Div YieldTTM8.90%Amplitude0.3610Historical Low0.6670Avg Price1Lot Size
Trending Stocks
Discussing
Trump 2.0 Era: What's the next opportunity in the markets?
▪️Could Trump's crypto policies potentially benefit the crypto market? ▪️Might his tariff policies have a positive effect on Chinese stocks
Michael McCarthy CCO
Jan 3 11:57
Ask a strategist - Trump's first day
NovaBay Pharmaceuticals Stock Forum
NovaBay Pharmaceuticals Completes the Sale of its Eyecare Business to PRN and Further Adjourns its Special Meeting of Stockholders on Dissolution Proposal
Thursday, 23rd January at 8:00 am
Stockholders voted to unlock the value of NovaBay's Avenova® eyecare business by approving the $11.5 million asset sale
Reconvened Special Meeting adjourned to allow additional time for votes to reach the 50% threshold of outstanding common stock in favor of Proposal Two...
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
8. With regards t...
NovaBay Pharmaceuticals Sells Wound Care Trademarks NeutroPhase, PhaseOne, And OmniPhase To Phase One Health For $500K
$Ascent Solar Technologies (ASTI.US)$- Following delivery and the successful completion of the on-orbi...
NovaBay Pharmaceuticals Accepts Revised Offer from PRN Physician Recommended Nutriceuticals, LLC and Enters into an Amendment to the Asset Purchase Agreement to Increase Purchase Price
NovaBay Pharmaceuticals (NYSE American: NBY) has accepted a revised offer from PRN Physician Recommended Nutriceuticals to increase the purchase price for its eyecare business from $9.5 million to $11.5 million. The deal includes a secured promissory note of up to $1.0 million...
No comment yet